Morales Ortega X, Wolff Fernández C, Leal Ibarra T, Montaña Navarro N, Armas-Merino R
Departamento de Medicina Occidente, Hospital San Juan de Dios, Universidad de Chile, Santiago, Chile.
Medicina (B Aires). 1999;59(1):23-7.
The experience of 30 porphyric crisis is reviewed in 25 patients attended since 1967: 21 patients had 1 crisis, 3 had 2, and 1 had 3 of these episodes. In all patients, porphyria was diagnosed in relation to one crisis, even though many of them had family histories and/or previous clinical symptoms of this disease. There was clear predominance (80%) of women, but they are also a majority among acute porphyrias. The most frequent symptoms were: abdominal pain, tachycardia, dark urine, neurological and psychiatric alterations and arterial hypertension. The neurological alterations required the use of a respirator in 9 crisis (33%), which was maintained in 2 patients during 4 months. In 6 crisis (20%) there were no neurological symptoms. Among laboratory tests, hyponatremia was notable for its frequency (53.4%) and intensity. Increase in urinary porphobilinogen, a requirement for diagnosis, between 15 and 130 times the normal value was observed. Septic complications, such as pneumonia, septicemia, and urinary infection, were frequent (50%). Factors suspicious of triggering crisis episodes were: drugs, usually more than 2, in 50% of the cases; pregnancy in 30% of the women and in a lesser proportion, intense exercise, and surgery. In 10 patients, crisis triggering factors were not identified or informed. The role of pregnancy, childbirth delivery or puerperium in causing a crisis is not clear, because the patients who had a crisis related to them had 15 other pregnancies without incidents; besides, in the pregnancy which was accompanied by a crisis, there was always one or more than one potentially triggering drug present. The first therapeutic step was oral and/or parenteral administration of an overload of carbohydrates and, if there was no response, intravenous infusion of hematin was prescribed. Four (13.3%) patients died even though they had received hematin, but it had been administered too late due to a delay in diagnosis. In surviving patients, there were no organic sequels of any kind.
回顾了自1967年以来收治的25例患者中30次卟啉症危象的情况:21例患者经历了1次危象,3例经历了2次,1例经历了3次。在所有患者中,卟啉症均是在一次危象发作时被诊断出来的,尽管他们中的许多人有家族病史和/或该疾病先前的临床症状。女性明显占多数(80%),但在急性卟啉症患者中她们也是多数。最常见的症状有:腹痛、心动过速、深色尿液、神经和精神改变以及动脉高血压。在9次危象发作(33%)中,神经改变需要使用呼吸机,其中2例患者持续使用了4个月。在6次危象发作(20%)中没有神经症状。在实验室检查中,低钠血症因其出现频率(53.4%)和严重程度而值得注意。尿卟胆原增加是诊断的必要条件,观察到其值在正常范围的15至130倍之间。感染性并发症,如肺炎、败血症和尿路感染很常见(50%)。可疑的引发危象发作的因素有:药物,通常超过2种,在50%的病例中;30%的女性患者妊娠,还有比例较小的剧烈运动和手术。在10例患者中,未识别或被告知危象引发因素。妊娠、分娩或产褥期在引发危象中的作用尚不清楚,因为与这些情况相关而发生危象的患者还有15次其他妊娠未出现问题;此外,在伴有危象的那次妊娠中,总是存在一种或多种潜在引发药物。首要治疗步骤是口服和/或胃肠外给予过量碳水化合物,如果没有反应,则开具静脉输注血红素的处方。4例(13.3%)患者尽管接受了血红素治疗仍死亡,但由于诊断延误,血红素给药过晚。在存活患者中,没有出现任何类型的器质性后遗症。